CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 102 filers reported holding CHEMOCENTRYX INC in Q3 2019. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $419,000 | -41.3% | 45,000 | -12.5% | 0.01% | -35.7% |
Q1 2019 | $714,000 | +35.5% | 51,400 | +6.4% | 0.01% | +27.3% |
Q4 2018 | $527,000 | -21.5% | 48,300 | -9.0% | 0.01% | -8.3% |
Q3 2018 | $671,000 | -10.5% | 53,100 | -6.7% | 0.01% | -7.7% |
Q2 2018 | $750,000 | -30.2% | 56,900 | -28.0% | 0.01% | -31.6% |
Q1 2018 | $1,075,000 | +134.7% | 79,000 | +2.5% | 0.02% | +137.5% |
Q4 2017 | $458,000 | +23.5% | 77,100 | +54.2% | 0.01% | -11.1% |
Q3 2017 | $371,000 | -4.9% | 50,000 | +20.2% | 0.01% | 0.0% |
Q2 2017 | $390,000 | – | 41,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |